Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

23. Februar 2022 02:00 ET | Quelle: iosBio

iosBio receives UK grant to develop oral vaccine against Nipah virus

PRESS RELEASE iosBio receives UK grant to develop oral vaccine against Nipah virus Zoonotic virus often cited as future pandemic threat and requiring urgent R&D actioniosBio’s oral vaccine...
14. Juni 2021 02:00 ET | Quelle: iosBio

iosBio appoints Patricia Londono-Hayes as Chief Development Officer

PRESS RELEASE iosBio appoints Patricia Londono-Hayes as Chief Development Officer Oral vaccines and biotherapeutics company strengthens senior leadership team with new role to drive priority...
12. Januar 2021 07:00 ET | Quelle: iosBio

iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19

PRESS RELEASE iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19 iosBio licenses its OraProTM...
12. Januar 2021 02:00 ET | Quelle: iosBio

iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19

PRESS RELEASE iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19 iosBio licenses its OraProTM...
30. September 2020 02:00 ET | Quelle: iosBio

Stabilitech Biopharma announces name change to iosBio

PRESS RELEASE Stabilitech Biopharma announces name change to iosBio Burgess Hill, UK, 30 September 2020, STABILITECH BIOPHARMA (the “Company”), a UK-based biotechnology company developing next...